Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS, Ridder DA, Goeppert B, Brobeil A, Stenzel P, Zimmer S, Jäkel J, Metzig MO, Schwab R, Martin SZ, Kiss A, Bergmann F, Schirmacher P, Galle PR, Lang H, Roth W, Straub BK. Gerber TS, et al. Among authors: ridder da. Int J Cancer. 2024 May 15;154(10):1857-1868. doi: 10.1002/ijc.34836. Epub 2024 Jan 11. Int J Cancer. 2024. PMID: 38212892 Free article.
N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas.
Gerber TS, Goeppert B, Hausen A, Witzel HR, Bartsch F, Schindeldecker M, Gröger LK, Ridder DA, Cahyadi O, Esposito I, Gaida MM, Schirmacher P, Galle PR, Lang H, Roth W, Straub BK. Gerber TS, et al. Among authors: ridder da. Cancers (Basel). 2022 Jun 23;14(13):3091. doi: 10.3390/cancers14133091. Cancers (Basel). 2022. PMID: 35804866 Free PMC article.
Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations.
Gerber TS, Müller L, Bartsch F, Gröger LK, Schindeldecker M, Ridder DA, Goeppert B, Möhler M, Dueber C, Lang H, Roth W, Kloeckner R, Straub BK. Gerber TS, et al. Among authors: ridder da. Cancers (Basel). 2022 Jun 28;14(13):3156. doi: 10.3390/cancers14133156. Cancers (Basel). 2022. PMID: 35804931 Free PMC article.
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome.
Ridder DA, Urbansky LL, Witzel HR, Schindeldecker M, Weinmann A, Berndt K, Gerber TS, Köhler BC, Nichetti F, Ludt A, Gehrke N, Schattenberg JM, Heinrich S, Roth W, Straub BK. Ridder DA, et al. Cancers (Basel). 2022 Jan 15;14(2):430. doi: 10.3390/cancers14020430. Cancers (Basel). 2022. PMID: 35053591 Free PMC article.
Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence: potential implications for salvage liver transplantation?
Heinrich S, Mittler J, Theurer J, Ridder DA, Marquardt JU, Weinmann A, Scheuermann U, Otto G, Galle PR, Straub BK, Lang H. Heinrich S, et al. Among authors: ridder da. Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):183-191. doi: 10.21037/hbsn-21-346. Epub 2022 Mar 3. Hepatobiliary Surg Nutr. 2023. PMID: 37124699 Free PMC article.
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis.
Czauderna C, Poplawski A, O'Rourke CJ, Castven D, Pérez-Aguilar B, Becker D, Heilmann-Heimbach S, Odenthal M, Amer W, Schmiel M, Drebber U, Binder H, Ridder DA, Schindeldecker M, Straub BK, Galle PR, Andersen JB, Thorgeirsson SS, Park YN, Marquardt JU. Czauderna C, et al. Among authors: ridder da. JCI Insight. 2021 Sep 8;6(17):e146196. doi: 10.1172/jci.insight.146196. JCI Insight. 2021. PMID: 34375307 Free PMC article.
33 results